24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…
Gilead shares were up handily on Wednesday after the company announced that it had entered into a strategic collaboration with Precision BioSciences.
Chris Lange The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The top analyst upgrades, downgrades and other research calls from Thursday include Dolby Laboratories, Facebook, Freeport-McMoRan, Gilead, GrubHub and Skechers.
Gilead reported its most recent quarterly results after the markets closed on Wednesday. The major biotech posted $1.91 in earnings per share (EPS) and $5.65 billion in revenue, versus with consensus estimates…
Chris Lange Gilead is scheduled to release its second-quarter financial results after the markets close on Wednesday, and analyst expectations are low.
Chris Lange The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
RBC feels these seven top companies will still be very relevant in 2025, and the goods or services they provide potentially will become the norm across the globe. All are great picks…
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall…
